Image-guided radiation therapy developer ViewRay has raised approximately $50 million through the release and sale of 8.4 million shares of common stock.
The purchase price for each share was $5.95. Immediately after the closing, one new investor will own 9.9% of the company's outstanding shares.
ViewRay plans to use the proceeds for the ongoing commercialization of its MRIdian linear accelerator technology, for research and development related to continued product development activities, and for general corporate purposes, including working capital.
